GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » Sale Of Business

Ryvu Therapeutics (WAR:RVU) Sale Of Business : zł0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics Sale Of Business?

Ryvu Therapeutics's sale of business for the three months ended in Sep. 2024 was zł0.00 Mil. It means Ryvu Therapeutics gained zł0.00 Mil from selling business. Ryvu Therapeutics's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.00 Mil.

Compared with last quarter (zł0.00 Mil in Jun. 2024 ), Ryvu Therapeutics gained the same money from selling business in Sep. 2024 (zł0.00 Mil).


Ryvu Therapeutics Sale Of Business Historical Data

The historical data trend for Ryvu Therapeutics's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics Sale Of Business Chart

Ryvu Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ryvu Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ryvu Therapeutics Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ryvu Therapeutics Sale Of Business Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryvu Therapeutics Business Description

Traded in Other Exchanges
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines